Literature DB >> 24876722

Significance of viral status on occurrence of hepatitis B-related hepatocellular carcinoma.

Li-Shuai Qu1, Guo-Xiong Zhou1.   

Abstract

Hepatitis B virus (HBV) infection remains a challenging global health problem, with more than 350 million people chronically infected and at risk of developing hepatocellular carcinoma (HCC). Interactions that occur among host, environmental, and viral factors determine the natural course and predict the prognosis of patients with chronic HBV infection. In the past decades, several important viral factors of predictive of HCC have been identified, such as high hepatitis B surface antigen level, seropositivity of hepatitis B e antigen, high viral load, viral genotype, and specific viral sequence mutations. Identification of certain viral risk factors for HCC development and stratification of patient risk are very important to perform future surveillance programs. In this article, we thus reviewed the risk of viral factors involved in hepatocarcinogenesis.

Entities:  

Keywords:  Genotype; Hepatitis B virus; Hepatocellular carcinoma; Mutation; Serum hepatitis B virus-DNA levels

Mesh:

Substances:

Year:  2014        PMID: 24876722      PMCID: PMC4033439          DOI: 10.3748/wjg.v20.i20.5999

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  70 in total

Review 1.  Hepatitis B virus infection.

Authors:  W M Lee
Journal:  N Engl J Med       Date:  1997-12-11       Impact factor: 91.245

2.  Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.

Authors:  Tai-Chung Tseng; Chun-Jen Liu; Tung-Hung Su; Chia-Chi Wang; Chi-Ling Chen; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Gastroenterology       Date:  2011-04-28       Impact factor: 22.682

3.  Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma.

Authors:  Yasuhito Tanaka; Motokazu Mukaide; Etsuro Orito; Man-Fung Yuen; Kiyoaki Ito; Fuat Kurbanov; Fuminaka Sugauchi; Yasuhiro Asahina; Namiki Izumi; Michio Kato; Ching-Lung Lai; Ryuzo Ueda; Masashi Mizokami
Journal:  J Hepatol       Date:  2006-08-10       Impact factor: 25.083

4.  Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21.

Authors:  Yuehua Huang; Shuping Tong; Andrew W Tai; Munira Hussain; Anna S F Lok
Journal:  Gastroenterology       Date:  2011-06-24       Impact factor: 22.682

5.  Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B.

Authors:  Pok Yeung; Danny Ka-Ho Wong; Ching-Lung Lai; James Fung; Wai-Kay Seto; Man-Fung Yuen
Journal:  J Infect Dis       Date:  2011-01-12       Impact factor: 5.226

6.  Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan.

Authors:  Sheng-Nan Lu; Wei-Wen Su; Sheng-Shun Yang; Ting-Tsung Chang; Ken-Sheng Cheng; Jaw-Ching Wu; Hans Hsienhong Lin; Shun-Sheng Wu; Chuan-Mo Lee; Chi-Sin Changchien; Chien-Jen Chen; Jin-Chuan Sheu; Ding-Shinn Chen; Chien-Hung Chen
Journal:  Int J Cancer       Date:  2006-10-15       Impact factor: 7.396

7.  Blocking of G1/S transition and cell death in the regenerating liver of Hepatitis B virus X protein transgenic mice.

Authors:  Bo-Kuan Wu; Chao-Chin Li; Huei-Jane Chen; Junn-Liang Chang; King-Song Jeng; Chen-Kung Chou; Ming-Ta Hsu; Ting-Fen Tsai
Journal:  Biochem Biophys Res Commun       Date:  2005-12-27       Impact factor: 3.575

8.  Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America.

Authors:  Patricia Arauz-Ruiz; Helene Norder; Betty H Robertson; Lars O Magnius
Journal:  J Gen Virol       Date:  2002-08       Impact factor: 3.891

9.  Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress.

Authors:  Hui-Ching Wang; Han-Chieh Wu; Chien-Fu Chen; Nelson Fausto; Huan-Yao Lei; Ih-Jen Su
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

Review 10.  Hepatitis B virus immunopathogenesis.

Authors:  F V Chisari; C Ferrari
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

View more
  2 in total

1.  Risk of HCC With Hepatitis B Viremia Among HIV/HBV-Coinfected Persons in North America.

Authors:  H Nina Kim; Craig W Newcomb; Dena M Carbonari; Jason A Roy; Jessie Torgersen; Keri N Althoff; Mari M Kitahata; K Rajender Reddy; Joseph K Lim; Michael J Silverberg; Angel M Mayor; Michael A Horberg; Edward R Cachay; Gregory D Kirk; Jing Sun; Mark Hull; M John Gill; Timothy R Sterling; Jay R Kostman; Marion G Peters; Richard D Moore; Marina B Klein; Vincent Lo Re
Journal:  Hepatology       Date:  2021-06-22       Impact factor: 17.298

Review 2.  The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy.

Authors:  Ioannis Varbobitis; George V Papatheodoridis
Journal:  Clin Mol Hepatol       Date:  2016-09-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.